ImmuCell Corporation (ICCC)

ImmuCell Corporation (ICCC) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $98M; returns 1 day -1.8%, 1 week -4.7%, 1 year +69.1%.

ImmuCell Corporation (ICCC) is an animal health company focused on improving the health and productivity of dairy and beef cattle. It develops, manufactures, and markets products primarily for the prevention of neonatal calf diseases like scours. The company's flagship product is the First Defense® line, which provides immediate immunity to newborn calves against E.

Groups ICCC belongs to

ICCC financial model: income statement, cash flow and balance sheet